News|Articles|September 30, 2024

IMRT Yields Similar QOL Vs Proton Therapy in Localized Prostate Cancer

Author(s)Russ Conroy
Fact checked by: Harrison Widelitz

Data show no differences in bowel function between treatment arms based on factors including age, disease risk, and fractionation schedule.

Intensity-modulated radiation therapy (IMRT) and proton beam therapy yielded comparable quality of life (QOL) outcomes and effective tumor control among patients with localized prostate cancer, according to findings from the phase 3 Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL) trial (NCT01617161) presented in a press briefing at the 2024 American Society for Radiation Oncology Annual Meeting (ASTRO).1